Having trouble accessing articles? Reset your cache.

Non-toxigenic Clostridium difficile: Phase I data

In a dose-escalation, placebo-controlled, Swiss Phase I trial in healthy volunteers ages 18-45 and 60 and up, single- and

Read the full 192 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE